Cutrera, R., Wolfler, A., Picone, S., Rossi Giovanni, A., Gualberti, G., Merolla, R., et al. (2019). Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: a systematic review of seven Italian reports. THE ITALIAN JOURNAL OF PEDIATRICS, 45(1), 1-9 [10.1186/s13052-019-0736-5].
Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: a systematic review of seven Italian reports
Villani A;
2019-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
17_Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
686.67 kB
Formato
Adobe PDF
|
686.67 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
